Instrumental Soft Tissue Mobilization and Foam Rolling (IASTM)

March 18, 2026 updated by: DR. ZAHEEN AHMED IQBAL, Manav Rachna International Institute of Research and Studies

The Role of Instrumental Soft Tissue Mobilization and Foam Rolling in Managing Plantar Fasciitis: A Randomized Controlled Trial

This study compares instrument-assisted soft tissue mobilization (IASTM) and foam roller therapy in individuals with plantar fasciitis. Both groups receive structured exercises. The study evaluates changes in pain, ankle dorsiflexion range of motion, and functional ability after treatment to determine which intervention is more effective for improving symptoms and physical function.

Study Overview

Detailed Description

This randomized comparative study was conducted to evaluate the effectiveness of instrument-assisted soft tissue mobilization (IASTM) and foam roller therapy in the management of plantar fasciitis. Plantar fasciitis is a common musculoskeletal condition characterized by heel pain and reduced functional mobility, often associated with restricted ankle dorsiflexion and plantar fascia tightness.

Participants diagnosed with plantar fasciitis were recruited from a physiotherapy outpatient department and randomly allocated into two intervention groups. Group A received instrument-assisted soft tissue mobilization applied to the plantar fascia and surrounding soft tissues along with a structured exercise program. Group B received foam roller therapy targeting the plantar fascia region in addition to the same exercise protocol. Both interventions were administered over a defined treatment period under physiotherapist supervision.

The study aimed to compare the effects of these interventions on pain intensity, ankle dorsiflexion range of motion, and functional disability related to plantar fasciitis. Measurements were obtained at baseline and after completion of the intervention period. The findings of this study may help identify effective physiotherapy interventions for improving pain and functional outcomes in individuals with plantar fasciitis.

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Haryana
      • Faridabad, Haryana, India, 121004
        • MRIIRS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria

  • Age between 18 and 45 years
  • Pain on palpation at the medial tuberosity of the calcaneus
  • Pain during the first steps in the morning that decreases after walking
  • Symptoms present for more than one month
  • Both male and female participants were included Exclusion Criteria
  • History of foot surgery
  • Inflammatory rheumatic disease
  • Previous steroid injection
  • Radiculopathy affecting the lower limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
IASTM + Exercise
Instrument-assisted soft tissue mobilization applied to the plantar fascia and surrounding soft tissues to improve tissue mobility and reduce pain.
Active Comparator: 2
Foam Roller + Exercise
Self-myofascial release using a foam roller applied to the plantar fascia region to reduce pain and improve flexibility.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity measured using the Numeric Pain Rating Scale (NPRS)
Time Frame: Pre (baseline) and Post (4 weeks)
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain).
Pre (baseline) and Post (4 weeks)
Ankle dorsiflexion range of motion measured in degrees using a goniometer
Time Frame: Pre (baseline) and Post (4 weeks)
Ankle range of motion will be measured in degrees using a universal goniometer.
Pre (baseline) and Post (4 weeks)
Health-related quality of life measured using the Short Form-36 (SF-36) questionnaire
Time Frame: Pre (baseline) and Post (4 weeks)
Quality of life will be assessed using the Short Form-36 (SF-36) questionnaire, which evaluates physical and mental health domains. Each domain is scored separately and then transformed to a 0-100 scale, where higher scores indicate better health status and quality of life.
Pre (baseline) and Post (4 weeks)
Foot pain and disability measured using the Foot Function Index (FFI)
Time Frame: Pre (baseline) and Post (4 weeks)
Foot function and disability related to plantar fasciitis were measured using the Foot Function Index (FFI) questionnaire. Each item of the Foot Function Index (FFI) is rated on a Visual Analog Scale (VAS) from 0 to 10, where 0 indicates no pain or difficulty and 10 indicates the worst pain or extreme difficulty. Scores for the answered items in each subscale are summed and divided by the maximum possible score for that subscale, and the result is multiplied by 100 to obtain a percentage score (FFI Score = Sum of item scores / Maximum possible score × 100). The scores range from 0% to 100%, where 0% represents no pain or disability and 100% represents maximum pain and disability. Higher scores indicate greater pain, functional limitation, and disability related to foot problems. A total FFI score can be calculated by averaging the three subscale scores: Pain, Disability, and Activity Limitation.
Pre (baseline) and Post (4 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2025

Primary Completion (Actual)

June 15, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

March 11, 2026

First Submitted That Met QC Criteria

March 18, 2026

First Posted (Actual)

March 23, 2026

Study Record Updates

Last Update Posted (Actual)

March 23, 2026

Last Update Submitted That Met QC Criteria

March 18, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IASTMvsFR
  • MRIIRS/SAHS/PT/2024-25/009 (Other Grant/Funding Number: MRIIRS)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be publicly shared due to institutional and ethical restrictions related to participant confidentiality and consent agreements. However, summarized data supporting the findings of this study are available from the corresponding author upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plantar Fasciitis, Chronic

Clinical Trials on Instrument-Assisted Soft Tissue Mobilization (IASTM)

Subscribe